explore -WSS

explore

author：focus 2025-10-02 11:08:16 - browse：957

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： UnitedHealth’s Optum accused of antitrust violations in California

WSS

Despite FDA concern, risk that CAR

Will the market for weight loss drugs really reach $100 billion?

Bird flu researchers hone in on Finland’s mink farms

Judge sides with young activists in first

Patients, digital health players weigh in on FTC's data privacy plan

Aspartame and sugar

focus

explore

focus

Medical records are filled with copy

Indictment alleges Trump's ex

Medical leaders decry Supreme Court decision on affirmative action

Illumina slashes 2023 revenue projections yet again

In age of alternative facts, a scholarly course on calling out crap

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

DIEP, the 'gold standard' of breast reconstruction, is under threat

CDC director unscathed in first congressional testimony

Sports medicine is finally prioritizing gender equality

Novo Nordisk touts Wegovy study, but still struggling with supply

Wikipedia

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

What to do when lifesaving products contribute to climate change

Bird flu researchers hone in on Finland’s mink farms

Judge sides with young activists in first

Judge sides with young activists in first

30 years of 'Listening to Prozac'

hotspot

entertainment

Wikipedia

Wikipedia